Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 19 |
NetGPI | no | yes: 0, no: 20 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005759 | mitochondrial matrix | 5 | 21 |
GO:0031974 | membrane-enclosed lumen | 2 | 21 |
GO:0043233 | organelle lumen | 3 | 21 |
GO:0070013 | intracellular organelle lumen | 4 | 21 |
GO:0110165 | cellular anatomical entity | 1 | 21 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 122 | 124 | PF00675 | 0.345 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.265 |
CLV_NRD_NRD_1 | 243 | 245 | PF00675 | 0.359 |
CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.554 |
CLV_PCSK_FUR_1 | 123 | 127 | PF00082 | 0.247 |
CLV_PCSK_FUR_1 | 184 | 188 | PF00082 | 0.246 |
CLV_PCSK_KEX2_1 | 125 | 127 | PF00082 | 0.369 |
CLV_PCSK_KEX2_1 | 184 | 186 | PF00082 | 0.306 |
CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.554 |
CLV_PCSK_PC1ET2_1 | 125 | 127 | PF00082 | 0.247 |
CLV_PCSK_PC7_1 | 25 | 31 | PF00082 | 0.643 |
CLV_PCSK_SKI1_1 | 48 | 52 | PF00082 | 0.493 |
CLV_PCSK_SKI1_1 | 54 | 58 | PF00082 | 0.430 |
DOC_PP1_RVXF_1 | 3 | 9 | PF00149 | 0.441 |
DOC_PP4_FxxP_1 | 50 | 53 | PF00568 | 0.484 |
DOC_USP7_MATH_1 | 23 | 27 | PF00917 | 0.727 |
LIG_14-3-3_CanoR_1 | 5 | 9 | PF00244 | 0.560 |
LIG_14-3-3_CterR_2 | 244 | 248 | PF00244 | 0.531 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.440 |
LIG_BRCT_BRCA1_1 | 68 | 72 | PF00533 | 0.435 |
LIG_eIF4E_1 | 115 | 121 | PF01652 | 0.491 |
LIG_FHA_1 | 127 | 133 | PF00498 | 0.449 |
LIG_FHA_2 | 135 | 141 | PF00498 | 0.484 |
LIG_FHA_2 | 36 | 42 | PF00498 | 0.461 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.495 |
LIG_LIR_Apic_2 | 189 | 194 | PF02991 | 0.483 |
LIG_LIR_Apic_2 | 49 | 53 | PF02991 | 0.488 |
LIG_LIR_Gen_1 | 112 | 122 | PF02991 | 0.466 |
LIG_LIR_Gen_1 | 69 | 80 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 112 | 118 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 69 | 75 | PF02991 | 0.543 |
LIG_Pex14_2 | 4 | 8 | PF04695 | 0.620 |
LIG_SH2_CRK | 191 | 195 | PF00017 | 0.502 |
LIG_SH2_GRB2like | 115 | 118 | PF00017 | 0.559 |
LIG_SH2_GRB2like | 236 | 239 | PF00017 | 0.491 |
LIG_SH2_NCK_1 | 168 | 172 | PF00017 | 0.582 |
LIG_SH2_STAP1 | 168 | 172 | PF00017 | 0.528 |
LIG_SH2_STAT3 | 230 | 233 | PF00017 | 0.487 |
LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.487 |
LIG_SH2_STAT5 | 168 | 171 | PF00017 | 0.581 |
LIG_SH2_STAT5 | 210 | 213 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 236 | 239 | PF00017 | 0.479 |
LIG_SH3_3 | 49 | 55 | PF00018 | 0.462 |
LIG_SUMO_SIM_anti_2 | 140 | 146 | PF11976 | 0.467 |
LIG_SUMO_SIM_par_1 | 89 | 96 | PF11976 | 0.421 |
LIG_TRAF2_1 | 152 | 155 | PF00917 | 0.559 |
LIG_UBA3_1 | 56 | 62 | PF00899 | 0.456 |
LIG_UBA3_1 | 90 | 97 | PF00899 | 0.289 |
LIG_WW_3 | 51 | 55 | PF00397 | 0.378 |
MOD_CK1_1 | 135 | 141 | PF00069 | 0.433 |
MOD_CK2_1 | 35 | 41 | PF00069 | 0.456 |
MOD_CK2_1 | 4 | 10 | PF00069 | 0.623 |
MOD_CK2_1 | 89 | 95 | PF00069 | 0.439 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.651 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.368 |
MOD_GlcNHglycan | 66 | 69 | PF01048 | 0.574 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.564 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.580 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.526 |
MOD_N-GLC_1 | 166 | 171 | PF02516 | 0.287 |
MOD_NEK2_1 | 132 | 137 | PF00069 | 0.485 |
MOD_NEK2_1 | 4 | 9 | PF00069 | 0.625 |
MOD_NEK2_2 | 35 | 40 | PF00069 | 0.564 |
MOD_PKA_1 | 186 | 192 | PF00069 | 0.377 |
MOD_PKA_2 | 186 | 192 | PF00069 | 0.444 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.641 |
MOD_PKB_1 | 184 | 192 | PF00069 | 0.419 |
MOD_Plk_1 | 132 | 138 | PF00069 | 0.529 |
MOD_Plk_2-3 | 201 | 207 | PF00069 | 0.491 |
TRG_DiLeu_BaEn_4 | 111 | 117 | PF01217 | 0.559 |
TRG_DiLeu_BaLyEn_6 | 238 | 243 | PF01217 | 0.491 |
TRG_DiLeu_BaLyEn_6 | 52 | 57 | PF01217 | 0.507 |
TRG_ENDOCYTIC_2 | 115 | 118 | PF00928 | 0.486 |
TRG_ER_diArg_1 | 184 | 187 | PF00400 | 0.486 |
TRG_ER_diArg_1 | 28 | 30 | PF00400 | 0.566 |
TRG_NES_CRM1_1 | 140 | 154 | PF08389 | 0.530 |
TRG_NLS_MonoCore_2 | 122 | 127 | PF00514 | 0.467 |
TRG_NLS_MonoExtC_3 | 123 | 128 | PF00514 | 0.467 |
TRG_NLS_MonoExtN_4 | 123 | 128 | PF00514 | 0.467 |
TRG_Pf-PMV_PEXEL_1 | 32 | 36 | PF00026 | 0.558 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P990 | Leptomonas seymouri | 27% | 100% |
A0A0N1HS24 | Leptomonas seymouri | 72% | 97% |
A0A0S4ITN8 | Bodo saltans | 30% | 100% |
A0A1X0NTH7 | Trypanosomatidae | 65% | 95% |
A0A1X0P207 | Trypanosomatidae | 30% | 100% |
A0A3Q8IBW7 | Leishmania donovani | 28% | 100% |
A0A3Q8IFM4 | Leishmania donovani | 85% | 97% |
A0A422P4Z7 | Trypanosoma rangeli | 28% | 100% |
A4HI52 | Leishmania braziliensis | 28% | 100% |
A4I007 | Leishmania infantum | 85% | 97% |
A4I5C8 | Leishmania infantum | 28% | 100% |
C9ZQR0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
C9ZSQ9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 95% |
C9ZU92 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 22% | 67% |
E9AVY0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 81% | 100% |
E9B0M6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
Q4Q7K6 | Leishmania major | 28% | 86% |
Q4QBJ9 | Leishmania major | 83% | 100% |
V5BDB3 | Trypanosoma cruzi | 64% | 95% |